Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy

Engineering and application of nanomaterials have recently helped advance various biomedical fields. Zinc oxide (ZnO)-based nanocomposites have become one of the most promising candidates for biomedical applications due to their biocompatibility, unique physicochemical properties, and cost-effective...

Full description

Bibliographic Details
Main Authors: Prashant Sharma, Na-Yoon Jang, Jae-Won Lee, Bum Chul Park, Young Keun Kim, Nam-Hyuk Cho
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/11/10/493
_version_ 1828276722776145920
author Prashant Sharma
Na-Yoon Jang
Jae-Won Lee
Bum Chul Park
Young Keun Kim
Nam-Hyuk Cho
author_facet Prashant Sharma
Na-Yoon Jang
Jae-Won Lee
Bum Chul Park
Young Keun Kim
Nam-Hyuk Cho
author_sort Prashant Sharma
collection DOAJ
description Engineering and application of nanomaterials have recently helped advance various biomedical fields. Zinc oxide (ZnO)-based nanocomposites have become one of the most promising candidates for biomedical applications due to their biocompatibility, unique physicochemical properties, and cost-effective mass production. In addition, recent advances in nano-engineering technologies enable the generation of ZnO nanocomposites with unique three-dimensional structures and surface characteristics that are optimally designed for in vivo applications. Here, we review recent advances in the application of diverse ZnO nanocomposites, with an especial focus on their development as vaccine adjuvant and cancer immunotherapeutics, as well as their intrinsic properties interacting with the immune system and potential toxic effect in vivo. Finally, we summarize promising proof-of-concept applications as prophylactic and therapeutic vaccines against infections and cancers. Understanding the nano-bio interfaces between ZnO-based nanocomposites and the immune system, together with bio-effective design of the nanomaterial using nano-architectonic technology, may open new avenues in expanding the biomedical application of ZnO nanocomposites as a novel vaccine platform.
first_indexed 2024-04-13T07:01:41Z
format Article
id doaj.art-07afd9ed216844909f52c28123918f0b
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-13T07:01:41Z
publishDate 2019-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-07afd9ed216844909f52c28123918f0b2022-12-22T02:57:05ZengMDPI AGPharmaceutics1999-49232019-09-01111049310.3390/pharmaceutics11100493pharmaceutics11100493Application of ZnO-Based Nanocomposites for Vaccines and Cancer ImmunotherapyPrashant Sharma0Na-Yoon Jang1Jae-Won Lee2Bum Chul Park3Young Keun Kim4Nam-Hyuk Cho5Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Materials Science and Engineering, Korea University, Seoul 02841, KoreaDepartment of Materials Science and Engineering, Korea University, Seoul 02841, KoreaDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03080, KoreaEngineering and application of nanomaterials have recently helped advance various biomedical fields. Zinc oxide (ZnO)-based nanocomposites have become one of the most promising candidates for biomedical applications due to their biocompatibility, unique physicochemical properties, and cost-effective mass production. In addition, recent advances in nano-engineering technologies enable the generation of ZnO nanocomposites with unique three-dimensional structures and surface characteristics that are optimally designed for in vivo applications. Here, we review recent advances in the application of diverse ZnO nanocomposites, with an especial focus on their development as vaccine adjuvant and cancer immunotherapeutics, as well as their intrinsic properties interacting with the immune system and potential toxic effect in vivo. Finally, we summarize promising proof-of-concept applications as prophylactic and therapeutic vaccines against infections and cancers. Understanding the nano-bio interfaces between ZnO-based nanocomposites and the immune system, together with bio-effective design of the nanomaterial using nano-architectonic technology, may open new avenues in expanding the biomedical application of ZnO nanocomposites as a novel vaccine platform.https://www.mdpi.com/1999-4923/11/10/493zno nanocompositevaccinecancerimmunotherapytoxicityimmune cells
spellingShingle Prashant Sharma
Na-Yoon Jang
Jae-Won Lee
Bum Chul Park
Young Keun Kim
Nam-Hyuk Cho
Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
Pharmaceutics
zno nanocomposite
vaccine
cancer
immunotherapy
toxicity
immune cells
title Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
title_full Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
title_fullStr Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
title_full_unstemmed Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
title_short Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
title_sort application of zno based nanocomposites for vaccines and cancer immunotherapy
topic zno nanocomposite
vaccine
cancer
immunotherapy
toxicity
immune cells
url https://www.mdpi.com/1999-4923/11/10/493
work_keys_str_mv AT prashantsharma applicationofznobasednanocompositesforvaccinesandcancerimmunotherapy
AT nayoonjang applicationofznobasednanocompositesforvaccinesandcancerimmunotherapy
AT jaewonlee applicationofznobasednanocompositesforvaccinesandcancerimmunotherapy
AT bumchulpark applicationofznobasednanocompositesforvaccinesandcancerimmunotherapy
AT youngkeunkim applicationofznobasednanocompositesforvaccinesandcancerimmunotherapy
AT namhyukcho applicationofznobasednanocompositesforvaccinesandcancerimmunotherapy